Stay updated on ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedAdded revision v3.4.3 to the record history and removed the previous v3.4.2 entry.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe page shows a minor site version update: Revision v3.4.2 added and Revision v3.4.1 removed. This change does not affect the study data or history content displayed on the page.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision history shows the addition of v3.4.1 and the deletion of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedThe Record History shows a new revision entry (v3.3.4) added and the previous revision (v3.3.3) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 in the page footer; these are administrative history/version updates and do not affect study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check112 days agoChange DetectedNew revision entry v3.3.2 added and v3.2.0 removed from the Record History page (NCT05446298). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.